Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Cardiovascular Drugs and Therapy|December 18, 2020
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?Maximilian Tscharre, Patricia P Wadowski, Constantin Weikert, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|April 28, 2022
Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y<sub>12</sub> InhibitorsPatricia P Wadowski, Joseph Pultar, Constantin Weikert, et al.
Atherosclerosis|May 22, 2018
YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patientsClemens Höbaus, Maximilian Tscharre, Carsten Thilo Herz, et al.
European Heart Journal. Acute Cardiovascular Care|November 20, 2016
Epicardial adipose tissue and cardiovascular outcome in patients with acute coronary syndrome undergoing percutaneous coronary interventionMaximilian Tscharre, Christina Hauser, Miklos Rohla, et al.
Open Heart|October 15, 2016
Systematic screening for cardiovascular risk at pharmaciesMiklos Rohla, Heinz Haberfeld, Helmut Sinzinger, et al.
Atherosclerosis|February 13, 2018
Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary interventionMaximilian Tscharre, Robert Herman, Miklos Rohla, et al.
Research and Practice in Thrombosis and Haemostasis|April 3, 2025
Elderly patients are hyperresponsive to potent P2Y12 inhibitorsDavid Mutschlechner, Maximilian Tscharre, Patricia Pia Wadowski, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 12, 2018
Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysisKris G Vargas, Paul M Haller, Bernhard Jäger, et al.
Biomedicines|September 27, 2025
Sex-Related Differences in On-Treatment Platelet Reactivity in Patients with Acute Coronary SyndromeDavid Mutschlechner, Anastasios Tsarouchas, Maximilian Tscharre, et al.
Atherosclerosis Plus|October 9, 2023
The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndromeEdita Pogran, Paul M Haller, Claudia Wegberger, et al.
Pageof 4